Table 2.
Changes in CVP, MAP, ABF and AR before and after intraportal injection of microspheres in experiment 2 (mean±SE).
| Pre-injection | Post-injection | Change (%) | |
| CVP (kPa) | |||
| Group 1 | 0.43±0.07 | 0.39±0.06 | -6.9±0.72 |
| Group 2 | 0.40±0.08 | 0.38±0.59 | -5.5±0.66 |
| Group 3 | 0.34±0.06 | 0.35±0.08 | 1.3±0.22 |
| MAP (kPa) | |||
| Group 1 | 12.7±0.4 | 7.9±0.4a | -38.1±1.9 |
| Group 2 | 12.9±0.6 | 8.4±0.5a | -35.4±2.1 |
| Group 3 | 12.9±0.4 | 13.1±0.4 | 1.5±0.2 |
| ABF (mL/min/ 100 g BW) | |||
| Group 1 | 4.2±0.3 | 3.4±0.3a | -21.3±2.6 |
| Group 2 | 3.7±0.2 | 3.1±0.2a | -16.8±2.5 |
| Group 3 | 4.1±0.3 | 4.2±0.3 | 2.1±0.1 |
| AR (kPa/mL/ min/100 g BW) | |||
| Group 1 | 3.1±0.1 | 2.4±0.1a | -21.0±2.3 |
| Group 2 | 3.5±0.1 | 2.7±0.1a | -21.7±2.3 |
| Group 3 | 3.3±0.2 | 3.2±0.2 | -0.4±0.1 |
Group 1: liver-innervated rats; group 2: liver-denervated rats; and group 3: control rats. CVP, central venous pressure; MAP, mean arterial pressure; ABF, aortic blood flow; AR, aortic resistance. aP<0.05 vs pre-injection.